JSB Market Research

Summary: Since hitting the market in 2015, drugs that target poly (ADP-ribose) polymerase (PARP) have transformed the clinical management of cancers harboring BRCA-mutations. As more PARP inhibitors have been commercialized, drug developers are turning their attention towards broadening drug labels and exploring combination strategies. This report covers the management of PARP inhibitors in the US, Europe, and Asia, focusing on efficacy and safety comparisons for approved products, current and future indications, and research and development strategies.                                                                       Get Free Sample Report:                                               ...

Summary The global pharmaceutical excipients market reached nearly $REDACTED billion in 2016 and is expected to grow at a REDACTED% compound annual growth rate (CAGR) over the next five years, driven by the increase in demand for oleochemicals and petrochemicals, to reach a value of $REDACTED billion in 2022.                                                                   Get Free Sample Report:                                                 Excipients in Pharmaceuticals: Global Markets to 2022 Report Scope This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry. A detailed anal...